Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules

International Immunology

Volumn 25, Issue 4, 2013, Pages 235-246

  Jiang, Yan ^a,b   Arase, Noriko ^b,c   Kohyama, Masako ^a,b   Hirayasu, Kouyuki ^a   Suenaga, Tadahiro ^a,b   Jin, Hui ^a,b   Matsumoto, Maki ^a   Shida, Kyoko ^a   Lanier, Lewis L ^d   Saito, Takashi ^a,e   Arase, Hisashi ^a,b,f  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RIKEN Center for Integrative Medical Sciences   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Antigen presentation; B cell activation; MHC class II; Misfolded protein

Indexed keywords

ANTIGEN; COMPLEMENTARY DNA; ENDOPLASMIC RETICULUM PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; DNA LIBRARY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN TRANSPORT; SCREENING TEST;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; AUTOANTIGENS; B-LYMPHOCYTES; CELL MEMBRANE; CHO CELLS; CRICETINAE; ENDOPLASMIC RETICULUM; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-C ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN TRANSPORT;

EID: 84875252096     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs155     Document Type: Article

References (30)

1. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L. and Wiley, D. C. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506.
2. Stern, L. J., Brown, J. H., Jardetzky, T. S. et al. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
3. Ghosh, P., Amaya, M., Mellins, E. and Wiley, D. C. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
4. Fremont, D. H., Hendrickson, W. A., Marrack, P. and Kappler, J. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
5. Chicz, R. M., Urban, R. G., Lane, W. S. et al. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764.
6. Rudensky, A. Y., Preston-Hurlburt, P., Hong, S. C., Barlow, A. and Janeway, C. A., Jr. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622.
7. Honey, K. and Rudensky, A. Y. 2003. Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3:472.
8. Neefjes, J., Jongsma, M. L., Paul, P. and Bakke, O. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11:823.
9. Busch, R., Cloutier, I., Sékaly, R. P. and Hämmerling, G. J. 1996. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15:418.
10. d-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8:319.
11. Giacomini, P., Beretta, A., Nicotra, M. R. et al. 1997. HLA-C heavy chains free of β2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsiveness. Tissue Antigens 50:555.
12. Stam, N. J., Spits, H. and Ploegh, H. L. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137:2299.
13. Shiratori, I., Ogasawara, K., Saito, T., Lanier, L. L. and Arase, H. 2004. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulinlike type 2 receptor. J. Exp. Med. 199:525.
14. Fan, Q. R., Garboczi, D. N., Winter, C. C., Wagtmann, N., Long, E. O. and Wiley, D. C. 1996. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl. Acad. Sci. U.S.A. 93:7178.
15. Sibilio, L., Martayan, A., Setini, A. et al. 2005. Impaired assembly results in the accumulation of multiple HLA-C heavy chain folding intermediates. J. Immunol. 175:6651.
16. Arosa, F. A., Santos, S. G. and Powis, S. J. 2007. Open conformers: the hidden face of MHC-I molecules. Trends Immunol. 28:115.
17. Kozono, H., White, J., Clements, J., Marrack, P. and Kappler, J. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369:151.
18. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
19. Ohkuri, T., Ueda, T., Tsurumaru, M. and Imoto, T. 2001. Evidence for an initiation site for hen lysozyme folding from the reduced form using its dissected peptide fragments. Protein Eng. 14:829.
20. Meusser, B., Hirsch, C., Jarosch, E. and Sommer, T. 2005. ERAD: the long road to destruction. Nat. Cell Biol. 7:766.
21. Nelson, C. A., Viner, N. J., Young, S. P., Petzold, S. J. and Unanue, E. R. 1996. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak. J. Immunol. 157:755.
22. Smith-Gill, S. J., Lavoie, T. B. and Mainhart, C. R. 1984. Antigenic regions defined by monoclonal antibodies correspond to structural domains of avian lysozyme. J. Immunol. 133:384.
23. Darsley, M. J. and Rees, A. R. 1985. Three distinct epitopes within the loop region of hen egg lysozyme defined with monoclonal antibodies. EMBO J. 4:383.
24. Satoh, T., Arii, J., Suenaga, T. et al. 2008. PILRa is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132:935.
25. Qi, H., Egen, J. G., Huang, A. Y. and Germain, R. N. 2006. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312:1672.
26. Batista, F. D. and Harwood, N. E. 2009. The who, how and where of antigen presentation to B cells. Nat. Rev. Immunol. 9:15.
27. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A. and Stevanovic, S. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213.
28. Castellino, F., Zappacosta, F., Coligan, J. E. and Germain, R. N. 1998. Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J. Immunol. 161:4048.
29. Sercarz, E. E. and Maverakis, E. 2003. MHC-guided processing: binding of large antigen fragments. Nat. Rev. Immunol. 3:621.
30. Davenport, M. P., Quinn, C. L., Chicz, R. M. et al. 1995. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR β-chain. Proc. Natl. Acad. Sci. U.S.A. 92:6567.